@FierceMedDev: Moving on from the Duet recall, Covidien gets a 510(k) for its next-gen surgical stapler. News | Follow @FierceMedDev
@MarkHFierce: Stent use can help certain patients more than medical therapy if used on the early side. Release | Follow @MarkHFierce
@DamianFierce: Joining other big shots in the device game, Medtronic has opened an R&D center in China. Report | Follow @DamianFierce
> Meridian Bioscience ($VIVO) is predicting a strong fiscal 2013, planning to notch between $190 million to $195 million on the strength of new diagnostic kits. Article
> Amid all the concern over the hackability of networked medical devices, one tech blogger suggests switching from Windows to Linux could boost software security. Story
> A new heart separation device improved three-year outcomes in heart failure patients. Release
> In Kenya, AIDS-prevention groups are lobbying the government to approve two minimally-invasive circumcision devices, citing study results saying circumcised men reduced risk of HIV infection by 65%. News
> The worldwide market for cancer diagnostics will explode over the next decade, according to a new study from ReportsnReports. More
> A new device that mechanically removed stroke-causing clots from blocked brain arteries performed well in a recent clinical trial. Item
Biotech News
@FierceBiotech: Special report: The Alzheimer's pipeline... What's next? Report | Follow @FierceBiotech
@JohnCFierce: Resverlogix touts positive PhIIb atherosclerosis data, sets sights on PhIII deal. More | Follow @JohnCFierce
@RyanMFierce: What changes will Roche vet Pascal Soriot make as CEO of AstraZeneca? More | Follow @RyanMFierce
> Alnylam reaps $29M harvest in new ag bio deal with Monsanto. News
> Analysis: Where will Pascal Soriot take AstraZeneca now? More
> FDA OK for HIV pill Quad sets up potential confrontation over Gilead's price. Article
Pharma News
@FiercePharma: AstraZeneca's gain is Roche's loss: Stock down 1% after $AZN woos away Pascal Soriot for CEO job. More | Follow @FiercePharma
> Forest adopts 'poison pill' to fend off Icahn. Report
> AstraZeneca entices Roche exec to take on CEO challenge. News
> Gilead draws early fire for new HIV med's $28K price. Story
Biotech Research News
> Acorda's drug treats nerve damage-related ED in preclinical test. Article
> Novira raises $23M for hepatitis B/HIV drug work. News
> Genentech, U. Minnesota scientists discover new colon cancer red flags. Story
> Johns Hopkins team turning blood cells into stem cells. More
> Melanoma stem cells may carry provocative drug target. Item
Pharma Manufacturing News
> Drugmaker EirGen thinks plan to put waste station nearby stinks. More
> Sun says FDA clears plants where Marshalls seized products in 2009. News
> CSL, whose vaccine was tied to convulsions, gets FDA closeout letter. Story
> Hospira commits to 200 jobs, $85M investment, at troubled plant. Report